GleamWall
中文EN

YCBD cbdMD, Inc.

Perfumes, Cosmetics & Other Toilet Preparations · NYSE · SEC CIK 1644903 · Fiscal year ends 09/30

Financial factors as of 2026-06-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY10.0%
TTM net income YoY-90.8%
TTM EPS YoY—
Revenue 3-yr CAGR-7.3%
Net income 3-yr CAGR—

Margins

Gross margin57.7%
Operating margin-13.9%
Net margin-13.8%
FCF margin-11.5%
EBITDA margin-12.8%

Returns

ROE-40.3%
ROA-25.1%
ROIC (approx.)-41.2%
Asset turnover1.82x

Leverage & solvency

Liabilities / assets37.5%
Debt / equity0.00x
Current ratio2.50x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.77x
Accruals ratio-5.8%
Payout ratio—
Capex / revenue0.9%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-06-302026Q22026-03-312025Q12025-12-312025Q4*2025-09-302025Q32025-06-302025Q22025-03-312025Q12024-12-312024Q4*2024-09-30
Income statement
Revenue$5.55M$5.64M$5.02M$4.72M$4.61M$4.75M$5.11M$4.56M
Cost of revenue$2.52M$2.38M$2.02M$1.94M$1.78M$1.79M$1.71M$2.10M
Gross profit$3.04M$3.26M$3.00M$2.78M$2.83M$2.96M$3.40M$2.45M
Operating income-$1.13M-$800,784-$286,288-$685,816-$904,686-$485,816-$86,272-$316,555
Pretax income-$1.13M-$797,978-$283,131-$679,968-$895,272-$480,757$15,095-$152,799
Net income-$1.13M-$797,978-$283,131-$679,968-$895,272-$480,757$15,095-$152,798
EBITDA-$1.09M-$756,078-$232,128-$615,028-$815,781-$391,187$20,468-$207,756
EPS (basic)-0.11-0.08-0.04—-0.21-1.90-1.73—
EPS (diluted)————————
Banking
Net interest income$3,275$2,806$3,157$5,848$9,414$7,642$11,404$2,051
Balance sheet
Cash & equivalents$2.12M$2.64M$3.39M$2.26M$1.06M$1.77M$1.97M$2.45M
Receivables$926,846$820,935$744,662$786,449$746,165$694,515$631,033$621,678
Inventory$3.47M$3.65M$3.14M$2.95M$3.18M$2.88M$2.47M$2.52M
Current assets$7.70M$8.38M$8.17M$6.55M$5.60M$6.19M$6.36M$6.39M
PP&E, net$334,840$361,119$388,018$277,377$345,361$432,792$511,915$454,268
Goodwill$190,000$190,000—$0————
Intangibles$1.98M$2.19M$2.12M$2.12M$2.32M$2.51M$2.70M$2.89M
Total assets$13.15M$12.25M$11.78M$10.42M$9.90M$10.94M$11.54M$10.58M
Current liabilities$3.08M$2.97M$2.77M$3.19M$3.58M$9.87M$9.17M$8.62M
Total liabilities$4.93M$2.97M$2.77M$3.19M$3.78M$10.27M$9.76M$8.62M
Shareholders' equity$8.21M$9.28M$9.01M$7.23M$6.11M$665,798$1.78M$1.96M
Shares outstanding11.12M10.50M10.07M8.92M8.91M783,3555.54M492,383
Cash flow statement
Operating cash flow-$442,158-$722,500-$812,464-$240,749-$704,200-$189,477-$317,949$167,377
Capital expenditure$18,065$5,748$164,802$2,804$1,475$15,506$164,387$10,000
Free cash flow-$460,223-$728,248-$977,266-$243,553-$705,675-$204,983-$482,336$157,377
Investing cash flow-$18,065$50,679-$164,802-$2,804-$1,475-$15,506-$164,387-$110,000
Financing cash flow-$59,681-$77,869$2.10M$1.45M$0$0$0$1
Depreciation & amortization$44,344$44,706$54,160$70,788$88,905$94,629$106,740$108,799
Dividends paid—————$1.00M$1.01M—

Free plan shows the latest 8 periods; Pro shows all 39 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.